Literature DB >> 15855482

Molecular characterization of vanB elements in naturally occurring gut anaerobes.

S A Ballard1, K K Pertile, M Lim, P D R Johnson, M L Grayson.   

Abstract

Previously, we reported the isolation of 10 vancomycin-resistant gram-positive anaerobic bacilli carrying the vanB ligase gene from nine hemodialysis patients (S. A. Ballard et al., Antimicrob. Agents Chemother. 49:77-81, 2005; T. P. Stinear et al., Lancet 357:855-856, 2001). In the present study, the molecular and evolutionary relationship of the vanB resistance element within these 10 anaerobes and two vancomycin-resistant Enterococcus faecium strains were examined. PCR analysis and nucleotide sequencing demonstrated that all 12 isolates carried the vanB operon associated with an element identical to Tn1549 and Tn5382 of Enterococcus. Restriction fragment length polymorphism analysis of the vanB operon in these isolates revealed two distinct patterns, and sequencing showed that minor base differences existed. PCR amplification of the joint region of a circular intermediate was demonstrated in nine of these organisms, a finding indicative of an ability to excise and circularize, an intermediate step in transposition and conjugative transfer. Southern hybridization with a vanB-vanX(B) probe suggests that there is one insert of the transposon in all isolates. Sequence analysis of the integration site revealed distinct sequences: the Tn1549/5382 element within E. faecium was inserted within the host chromosome, whereas nucleotide sequences surrounding the Tn1549/5382 element in the 10 anaerobes showed no significant homology to sequences in the GenBank database. We demonstrate considerable similarity between the Tn1549/5382 element identified in 10 anaerobe isolates with that found in enterococci. The homology and potential to transpose suggest a recent horizontal transfer event may have occurred. However, the original direction of transposition and the mechanism involved remains unknown.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855482      PMCID: PMC1087664          DOI: 10.1128/AAC.49.5.1688-1694.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  Regulation of VanA- and VanB-type glycopeptide resistance in enterococci.

Authors:  M Arthur; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Enterococcal vanB resistance locus in anaerobic bacteria in human faeces.

Authors:  T P Stinear; D C Olden; P D Johnson; J K Davies; M L Grayson
Journal:  Lancet       Date:  2001-03-17       Impact factor: 79.321

3.  Characterization of transposon Tn1549, conferring VanB-type resistance in Enterococcus spp.

Authors:  Fabien Garnier; Sead Taourit; Philippe Glaser; Patrice Courvalin; Marc Galimand
Journal:  Microbiology       Date:  2000-06       Impact factor: 2.777

4.  Prevalence of the vanB2 gene cluster in vanB glycopeptide-resistant enterococci in the United Kingdom and the Republic of Ireland and its association with a Tn5382-like element.

Authors:  K F McGregor; C Nolan; H K Young; M F Palepou; L Tysall; N Woodford
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

5.  Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains.

Authors:  Stephen Murchan; Mary Elizabeth Kaufmann; Ariane Deplano; Raf de Ryck; Marc Struelens; Christina Elsberg Zinn; Vivian Fussing; Saara Salmenlinna; Jaana Vuopio-Varkila; Névine El Solh; Christina Cuny; Wolfgang Witte; Panayotis T Tassios; Nikolas Legakis; Willem van Leeuwen; Alex van Belkum; Anna Vindel; Idoia Laconcha; Javier Garaizar; Saara Haeggman; Barbro Olsson-Liljequist; Ulrika Ransjo; Geoffrey Coombes; Barry Cookson
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

6.  Association between the vanB2 glycopeptide resistance operon and Tn1549 in enterococci from France.

Authors:  A Umeda; F Garnier; P Courvalin; M Galimand
Journal:  J Antimicrob Chemother       Date:  2002-08       Impact factor: 5.790

7.  Nonconjugative transposition of the vanB-containing Tn5382-like element in Enterococcus faecium.

Authors:  Kristin H Dahl; Torunn P Røkenes; Eirik W Lundblad; Arnfinn Sundsfjord
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli.

Authors:  S A Ballard; E A Grabsch; P D R Johnson; M L Grayson
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

9.  Geographic distribution of a large mobile element that transfers ampicillin and vancomycin resistance between Enterococcus faecium strains.

Authors:  J Hanrahan; C Hoyen; L B Rice
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 10.  Emergence of vancomycin-resistant enterococci.

Authors:  L B Rice
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more
  28 in total

1.  Eggerthella lenta bacteremia complicated by spondylodiscitis, psoas abscess, and meningitis.

Authors:  B J Gardiner; T M Korman; R K Junckerstorff
Journal:  J Clin Microbiol       Date:  2014-01-15       Impact factor: 5.948

2.  High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora.

Authors:  M-C Domingo; A Huletsky; R Giroux; K Boissinot; F J Picard; P Lebel; M J Ferraro; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  Clinical and microbiological characteristics of Eggerthella lenta bacteremia.

Authors:  B J Gardiner; A Y Tai; D Kotsanas; M J Francis; S A Roberts; S A Ballard; R K Junckerstorff; T M Korman
Journal:  J Clin Microbiol       Date:  2014-12-17       Impact factor: 5.948

4.  ICESluvan, a 94-kilobase mosaic integrative conjugative element conferring interspecies transfer of VanB-type glycopeptide resistance, a novel bacitracin resistance locus, and a toxin-antitoxin stabilization system.

Authors:  Eva K Bjørkeng; Erik Hjerde; Torunn Pedersen; Arnfinn Sundsfjord; Kristin Hegstad
Journal:  J Bacteriol       Date:  2013-09-27       Impact factor: 3.490

5.  Evaluation of the Xpert vanA/vanB assay using enriched inoculated broths for direct detection of vanB vancomycin-resistant Enterococci.

Authors:  X Zhou; J P Arends; G A Kampinga; H M Ahmad; B Dijkhuizen; P van Barneveld; J W A Rossen; A W Friedrich
Journal:  J Clin Microbiol       Date:  2014-10-08       Impact factor: 5.948

Review 6.  Mobile genetic elements of Staphylococcus aureus.

Authors:  Natalia Malachowa; Frank R DeLeo
Journal:  Cell Mol Life Sci       Date:  2010-07-29       Impact factor: 9.261

7.  Comparison of PCR and culture for screening of vancomycin-resistant Enterococci: highly disparate results for vanA and vanB.

Authors:  Anton Mak; Mark A Miller; George Chong; Yury Monczak
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

8.  Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice.

Authors:  Aline Launay; Susan A Ballard; Paul D R Johnson; M Lindsay Grayson; Thierry Lambert
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

9.  Improved detection of vanB2-containing enterococcus faecium with vancomycin susceptibility by Etest using oxgall supplementation.

Authors:  E A Grabsch; K Chua; S Xie; J Byrne; S A Ballard; P B Ward; M L Grayson
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

10.  Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA.

Authors:  K C Horne; B P Howden; E A Grabsch; M Graham; P B Ward; S Xie; B C Mayall; P D R Johnson; M L Grayson
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.